Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8239)
All Articles published online
|
Publishing Process of This Article
|
May 26, 2016 (publication date) through Jun 6, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Laine M, Paganelli F, Bonello L. P2Y12-ADP receptor antagonists: Days of future and past. World J Cardiol 2016; 8(5): 327-332 [PMID: 27231519 DOI: 10.4330/wjc.v8.i5.327] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v8/i5/327.htm |
| Number | Citing Articles |
| 1 |
Irini Sotiri, Matthew Robichaud, David Lee, Steffen Braune, Maud Gorbet, Buddy D. Ratner, John L. Brash, Robert A. Latour, Ilya Reviakine. BloodSurf 2017: News from the blood-biomaterial frontier. Acta Biomaterialia 2019; 87: 55 doi: 10.1016/j.actbio.2019.01.032
|
| 2 |
Ilya Reviakine, Friedrich Jung, Steffen Braune, John L. Brash, Robert Latour, Maud Gorbet, Wim van Oeveren. Stirred, shaken, or stagnant: What goes on at the blood–biomaterial interface. Blood Reviews 2017; 31(1): 11 doi: 10.1016/j.blre.2016.07.003
|
| 3 |
Margaret R. Cunningham, Riyaad Aungraheeta, Stuart J. Mundell. Pathophysiological consequences of receptor mistraffic: Tales from the platelet P2Y 12 receptor. Molecular and Cellular Endocrinology 2017; 449: 74 doi: 10.1016/j.mce.2017.02.016
|
| 4 |
Rohan M. Modi, Feng Li, Khalid Mumtaz, Alice Hinton, Scott M. Lilly, Hisham Hussan, Edward Levine, Cheng Zhang, Darwin L. Conwell, Somashekar G. Krishna, Peter P. Stanich. Colonoscopy in Patients With Postmyocardial Infarction Gastrointestinal Bleeding. Journal of Clinical Gastroenterology 2019; 53(1): 23 doi: 10.1097/MCG.0000000000000902
|
| 5 |
Angela Lowenstern, L. Kristin Newby. To Pretreat or Not to Pretreat (With Oral P2Y12 Antagonists)? That is the Question. Journal of the American Heart Association 2017; 6(9) doi: 10.1161/JAHA.117.007288
|
| 6 |
Wenxuan Wang, Qing Ma, Da Li, Wentai Zhang, Zhilu Yang, Wenjie Tian, Nan Huang. Engineered endothelium-mimicking antithrombotic surfaces via combination of nitric oxide-generation with fibrinolysis strategies. Bioactive Materials 2025; 43: 319 doi: 10.1016/j.bioactmat.2024.09.011
|
| 7 |
René Rothweiler, Vanessa Gerlach, Pit Voss, Philipp Poxleitner, Michael Ermer, Christian Gross, Christian Schwer, Kirstin Vach, Johannes Kalbhenn, Marc Metzger. Aspirin, heparin and ischemia time in microvascular free flap surgery - their influence and an optimal anticoagulation protocol. Journal of Stomatology, Oral and Maxillofacial Surgery 2022; 123(5): e556 doi: 10.1016/j.jormas.2022.03.001
|
| 8 |
Wen-jun Zhang, Mei-yong Li, Cheng-yi Wang, Xiao Feng, Dong-xia Hu, Li-dong Wu, Jia-ling Hu. P2Y12 receptor involved in the development of chronic nociceptive pain as a sensory information mediator. Biomedicine & Pharmacotherapy 2023; 164: 114975 doi: 10.1016/j.biopha.2023.114975
|
| 9 |
Jan Máchal, Ota Hlinomaz. Efficacy of P2Y12 Receptor Blockers After Myocardial Infarction and Genetic Variability of their Metabolic Pathways. Current Vascular Pharmacology 2018; 17(1): 35 doi: 10.2174/1570161116666180206110657
|
| 10 |
Younis Baqi, Christa E. Müller. Antithrombotic P2Y12 receptor antagonists: recent developments in drug discovery. Drug Discovery Today 2019; 24(1): 325 doi: 10.1016/j.drudis.2018.09.021
|
| 11 |
Christian Schoergenhofer, Eva‐Luise Hobl, Peter Schellongowski, Gottfried Heinz, Walter S. Speidl, Jolanta M. Siller‐Matula, Monika Schmid, Raute Sunder‐Plaßmann, Thomas Stimpfl, Matthias Hackl, Bernd Jilma. Clopidogrel in Critically Ill Patients. Clinical Pharmacology & Therapeutics 2018; 103(2): 217 doi: 10.1002/cpt.878
|
| 12 |
喜斌 高. Progress of Antiplatelet Therapy in Ischemic Stroke. Advances in Clinical Medicine 2020; 10(07): 1531 doi: 10.12677/ACM.2020.107229
|
| 13 |
M. Vidhya. P2Y12 receptor residues crucial for thrombosis regulation. Journal of Molecular Recognition 2023; 36(11) doi: 10.1002/jmr.3056
|
| 14 |
Huan-Huan Zhang, Wen-Ying Yu, Lan Li, Fang Wu, Qin Chen, Yang Yang, Chen-Huan Yu. Protective effects of diketopiperazines from Moslae Herba against influenza A virus-induced pulmonary inflammation via inhibition of viral replication and platelets aggregation. Journal of Ethnopharmacology 2018; 215: 156 doi: 10.1016/j.jep.2018.01.005
|
| 15 |
Atsumi Sone, Kensaku Aki, Toshiyuki Yasui, Eiji Hosoi. Inhibitory Effects of Aspirin and Cilostazol on Intracellular Ca<sup>2+</sup> Mobilization and Aggregation in Thrombin-activated Human Platelets. The Journal of Medical Investigation 2023; 70(1.2): 94 doi: 10.2152/jmi.70.94
|
| 16 |
Beata Olas, Karina Urbańska, Magdalena Bryś. Saponins as Modulators of the Blood Coagulation System and Perspectives Regarding Their Use in the Prevention of Venous Thromboembolic Incidents. Molecules 2020; 25(21): 5171 doi: 10.3390/molecules25215171
|
| 17 |
Zhangyu Lin, Sheng Yuan, Jining He, Yanjun Song, Wenjia Zhang, Kefei Dou. Novel insights on dual antiplatelet therapy duration following stenting for angiography-detected moderate-to-severe calcified coronary lesions. Pharmacological Research 2024; 208: 107378 doi: 10.1016/j.phrs.2024.107378
|
| 18 |
Larisa H. Cavallari, Aniwaa Owusu Obeng. Genetic Determinants of P2Y12 Inhibitors and Clinical Implications. Interventional Cardiology Clinics 2017; 6(1): 141 doi: 10.1016/j.iccl.2016.08.010
|